William Blair & Co.: Lantheus Holdings, Inc.- Initiation of Research Coverage
September 30, 2023
September 30, 2023
CHICAGO, Illinois, Sept. 30 (TNSres) -- William Blair and Co., an investment bank and financial services company, issued the following news:
William Blair initiated research coverage of Lantheus Holdings, Inc. (LNTH $65.90), a commercial-stage radiopharmaceuticals biotechnology company that markets Pylarify for imaging prostate cancer.
Analyst Andy T. Hsieh, Ph.D., estimated that the company would generate revenue of $1.26 billion in 2023, up from $0.94 billion in 2022, . . .
William Blair initiated research coverage of Lantheus Holdings, Inc. (LNTH $65.90), a commercial-stage radiopharmaceuticals biotechnology company that markets Pylarify for imaging prostate cancer.
Analyst Andy T. Hsieh, Ph.D., estimated that the company would generate revenue of $1.26 billion in 2023, up from $0.94 billion in 2022, . . .